Recalls should be spread like wildfire to protect consumers but it is especially important when it is an infant/child related recall.
Infant Ibuprofen Sold at CVS and Walmart has been recalled
Update: This still seems to be an active recalls as some medications still have an expiration date of 12/19.
A pharmaceutical company is expanding its recall of infant ibuprofen, which was originally issued in November 2018.
Tris Pharma, Inc. announced Wednesday that it is now voluntarily recalling three additional lots of Ibuprofen Oral Suspension Drops. They say some units from these batches have higher levels of ibuprofen concentrate which is super scary considering this is for infants and children.
According to Tris, there is a remote possibility that infants, who may be more susceptible to a higher potency level of drug, and therefore may be more vulnerable to permanent NSAID-associated renal injury.
Adverse effects that be experienced are nausea, vomiting, epigastric pain, or more rarely, diarrhea.
The affected brands include CVS Health and Equate, which is sold at Walmart. According to the Food and Drug Administration, the product is used as a pain reliever and fever reducer and is packaged in 0.5-ounce and 1-ounce bottles.
The product is used as a pain reliever/fever reducer and was packaged in 0.5 oz. bottles for the recalled lots listed below:
Wholesalers and retailers of the product should stop further distribution of the affected lots of Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, which are being recalled.
Consumers with questions regarding this recall can contact Tris Customer Service at 732-940-0358 (Monday through Friday, 8:00am ET- 5:00pm PT) or via email at Customer Service Email . Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Adverse reactions or quality problems experienced with the use of the product lots subject to this recall may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.